Home
News
Media coverage

Media coverage

Explore the Diverse Facets of Culture and Appreciate the Elegance of the Elderly. The

2025,04,14

Explore the Diverse Facets of Culture and Appreciate the Elegance of the Elderly. The "2025 Golden Age Health, Culture and Art Grand Exhibition" (Zhejiang Station) was officially launched in Dongtou.

Chengyi Pharmaceutical: The Capital Engine Drives the Marine Pharmaceutical Matrix

2025,04,03

Chengyi Pharmaceutical: The Capital Engine Drives the Marine Pharmaceutical Matrix

Marine Biomedicine: Blue Potions Bring Light to Life (with Stock Recommendations)

2025,03,28

Marine Biomedicine: Blue Potions Bring Light to Life (with Stock Recommendations)

2025,04,14

Explore the Diverse Facets of Culture and Appreciate the Elegance of the Elderly. The "2025 Golden Age Health, Culture and Art Grand Exhibition" (Zhejiang Station) was officially launched in Dongtou.

2025,04,03

Chengyi Pharmaceutical: The Capital Engine Drives the Marine Pharmaceutical Matrix

2025,03,28

Marine Biomedicine: Blue Potions Bring Light to Life (with Stock Recommendations)

2025,03,25

With the marine economy policy and the dual-drive of the entire industry chain, Chengyi Pharmaceutical is taking the lead in the new field of marine biomedicine.

2025,03,09

Silver Hair Economy Embraces Golden Opportunities: How Chengyi Pharmaceutical Can Ride the Wave?

2024,11,05

Exploring New Quality Productivity | Reporter Enters Cheng Yi Pharmaceutical, a Leader in Marine Biopharmaceuticals

2024,10,10

Cheng Yi Pharmaceutical actively repurchases shares to demonstrate long-term development confidence

2024,10,09

Cheng Yi Pharmaceutical: Significant repurchase of shares in mid to long term demonstrates confidence in long-term development

Wang Luo
2024,08,23

Continuously deepening and refining market and brand promotion, Cheng Yi Pharmaceutical's revenue in the first half of the year increased by 10.89% year-on-year

Data Treasure
2024,08,21

List of long-term heavy holdings of social security funds exposed

Popular Securities News
2024,08,21

Cheng Yi Pharmaceutical: Strong Core Product Power, Revenue Increased by 10.89% YoY in the First Half of the Year

2024,04,21

Cheng Yi Pharmaceutical insists on annual dividends to benefit all investors

<12...4 >

Contact Us

Address:Building9,Building20,FuliYuedu,Lane988,ShenhongRoad,MinhangDistrict,Shanghai,China

Tel:86-021-6575-2735

Fax:86-021-6522-9797

Mail:chyexport@chengyipharma.com